SE457958B - Vattenloeslig hemin-arginat eller hemin-lysinat-foerening, foerfarande foer framstaellning daerav samt anvaendning daerav foer tillverkning av medicinska kompositioner - Google Patents

Vattenloeslig hemin-arginat eller hemin-lysinat-foerening, foerfarande foer framstaellning daerav samt anvaendning daerav foer tillverkning av medicinska kompositioner

Info

Publication number
SE457958B
SE457958B SE8406263A SE8406263A SE457958B SE 457958 B SE457958 B SE 457958B SE 8406263 A SE8406263 A SE 8406263A SE 8406263 A SE8406263 A SE 8406263A SE 457958 B SE457958 B SE 457958B
Authority
SE
Sweden
Prior art keywords
hemin
water
arginine
arginate
acetone
Prior art date
Application number
SE8406263A
Other languages
English (en)
Swedish (sv)
Other versions
SE8406263D0 (sv
SE8406263L (sv
Inventor
G D Ingberg
R L A Penttilae
R O Tokola
R A Tenhunen
Original Assignee
Huhtamaeki Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huhtamaeki Oy filed Critical Huhtamaeki Oy
Publication of SE8406263D0 publication Critical patent/SE8406263D0/xx
Publication of SE8406263L publication Critical patent/SE8406263L/xx
Publication of SE457958B publication Critical patent/SE457958B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic System
    • C07F15/02—Iron compounds
    • C07F15/025—Iron compounds without a metal-carbon linkage
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
SE8406263A 1984-12-12 1984-12-10 Vattenloeslig hemin-arginat eller hemin-lysinat-foerening, foerfarande foer framstaellning daerav samt anvaendning daerav foer tillverkning av medicinska kompositioner SE457958B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB08431398A GB2168354B (en) 1984-12-12 1984-12-12 Hemin compound

Publications (3)

Publication Number Publication Date
SE8406263D0 SE8406263D0 (sv) 1984-12-10
SE8406263L SE8406263L (sv) 1986-06-11
SE457958B true SE457958B (sv) 1989-02-13

Family

ID=10571084

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8406263A SE457958B (sv) 1984-12-12 1984-12-10 Vattenloeslig hemin-arginat eller hemin-lysinat-foerening, foerfarande foer framstaellning daerav samt anvaendning daerav foer tillverkning av medicinska kompositioner

Country Status (12)

Country Link
JP (1) JPH0647541B2 (de)
AT (1) AT389308B (de)
BE (1) BE901319A (de)
CA (1) CA1242713A (de)
CH (1) CH666273A5 (de)
DE (1) DE3446887C2 (de)
FR (1) FR2574662B1 (de)
GB (1) GB2168354B (de)
LU (1) LU85716A1 (de)
NL (1) NL192682C (de)
SE (1) SE457958B (de)
SU (1) SU1384188A3 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0645681B2 (ja) * 1986-02-05 1994-06-15 美浜 久春 修飾ヘム
IT1245890B (it) * 1991-04-12 1994-10-25 Alfa Wassermann Spa Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
US7994217B2 (en) * 2002-05-02 2011-08-09 Xanodyne Pharmaceuticals, Inc. Prenatal multivitamin/multimineral supplement
RU2611636C1 (ru) * 2016-02-25 2017-02-28 Федеральное государственное бюджетное образовательное учреждение высшего образования Новосибирский государственный аграрный университет Гематоген
RU2671633C1 (ru) * 2017-11-30 2018-11-06 Общество с ограниченной ответственностью "ОКТАВА ХОЛДИНГ" Высокоэффективный гематоген

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2912M (fr) * 1963-07-24 1964-11-09 Rech S Pharma E R P H A R Soc Dichlorhydrate d'hématoporphyrinate de procaine.
JPS4930521A (de) * 1972-07-17 1974-03-19
JPS5144623A (ja) * 1974-10-14 1976-04-16 Green Cross Corp Chushayoasechirusarichirusanenno seiho
DE2527158A1 (de) * 1975-06-18 1976-12-23 Herz Eberhard Arzneimittel zur behandlung von infektionskrankheiten und von nicht nachweisbar durch mikroorganismen ausgeloeste entzuendungen in der human- und veterinaermedizin
JPS6021570B2 (ja) * 1978-07-04 1985-05-28 三共株式会社 ド−パ類の高濃度製剤の製法
JPS5780317A (en) * 1980-11-05 1982-05-19 Sumitomo Chem Co Ltd Preparation of pharmaceutical composition for injection
JPS57209211A (en) * 1981-06-18 1982-12-22 Shiseido Co Ltd Antimicrobial composition

Also Published As

Publication number Publication date
DE3446887C2 (de) 1994-05-05
BE901319A (fr) 1985-04-16
CA1242713A (en) 1988-10-04
FR2574662A1 (fr) 1986-06-20
SE8406263D0 (sv) 1984-12-10
ATA390784A (de) 1989-04-15
GB8431398D0 (en) 1985-01-23
DE3446887A1 (de) 1986-07-03
NL192682C (nl) 1997-12-02
AT389308B (de) 1989-11-27
LU85716A1 (fr) 1985-07-24
FR2574662B1 (fr) 1990-03-02
GB2168354B (en) 1988-12-07
NL8403782A (nl) 1986-07-01
SU1384188A3 (ru) 1988-03-23
CH666273A5 (de) 1988-07-15
JPS61172821A (ja) 1986-08-04
JPH0647541B2 (ja) 1994-06-22
NL192682B (nl) 1997-08-01
SE8406263L (sv) 1986-06-11
GB2168354A (en) 1986-06-18

Similar Documents

Publication Publication Date Title
Bonkowsky et al. Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin
CN1324234A (zh) 果糖胺氧化酶,拮抗剂和抑制剂
EP0264278B1 (de) Zusammensetzungen aus Vanadium und Peroxyd als Nachahmungsmittel von Insulin
JPH06511244A (ja) バナジウム組成物
JPS5838421B2 (ja) 分岐鎖状ケト酸のオルニチン及びアルギニン塩並びに肝臓及び腎臓障害の治療への使用
FI68970C (fi) Foerfarande foer framstaellning av en ny medicinskt anvaendbarhemin-foerening
CA2491763A1 (en) Blood glucose control with n-acylated glucosamines
CA2193551C (en) Eliminating agent for activated oxygen and free radicals
WO2006019855A1 (en) Compositions capable of inhibiting reactive oxygen and carbonyl species
SE457958B (sv) Vattenloeslig hemin-arginat eller hemin-lysinat-foerening, foerfarande foer framstaellning daerav samt anvaendning daerav foer tillverkning av medicinska kompositioner
Arbid et al. Effects of intraperitoneally injected vicine and convicine on the rat: Induction of favism‐like signs
AU2007209704B2 (en) Novel salts of substituted 5-membered azacycle and use thereof in the treatment of diseases related to protein aging
US6420419B1 (en) L-ascorbic acid 2-phosphate zinc salt and process for manufacturing the same
FR2534589A1 (fr) Procede pour la preparation d'une solution a usage pharmaceutique contenant un nouveau complexe mixte polynucleaire de fer iii comme ingredient actif
WO2009045122A1 (fr) Médicament destiné au traitement et à la prévention des complications liées au diabète sucré
JPH0859485A (ja) ３ーオキシゲルミルプロピオン酸化合物を主成分とするメイラード反応阻害剤
US6261588B1 (en) Prophylactics and remedies for renal diseases
DK172797B1 (da) Fremgangsmåde til fremstilling af et fysiologisk virksomt, vandopløseligt hæminkompleks samt anvendelse af dette til fremst
JP2001206893A (ja) 新規α−アミラーゼ阻害活性物質、その製造方法及びその用途
Shepard et al. PRIMARY HYPEROXALURIA: III. Nutritional and Metabolic Studies in a Patient
EP0759298B1 (de) Verwendung von 4-Amino-6-hydroxypyrazolo[3,4-d]pyrimidin zur Herstellung eines blutdrucksenkenden Mittels
NO160923B (no) Analogifremgangsmaate for fremstilling av fysiologisk virksomt, vannopploeselig hemin-arginat og hemin-lysinat.
US6239178B1 (en) Method of treating mammals
RU2177321C1 (ru) Селеновое каротинопротеиновое органическое вещество для регулирования метаболических процессов (его варианты)
JP2003119142A (ja) 糖化蛋白変性物質生成阻害剤

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8406263-7

Format of ref document f/p: F

NUG Patent has lapsed
NUG Patent has lapsed